Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997735 · ClinicalTrials.gov registry record · NA
Parent eReferral to Tobacco Quitline
A NA study of Secondhand Smoke, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 484
- Enrollment target
- 1
- Study location
NCT02997735: Completed NA study of Secondhand Smoke, sponsored by Children's Hospital of Philadelphia.
NCT02997735 is a NA study of Secondhand Smoke that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 484 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02997735, a NA study of Secondhand Smoke, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 484 participants
- Enrollment target
- 1
- Study location
Study Summary
Secondhand smoke (SHS) exposure is a significant public health problem in that it both harms children and is widely prevalent, affecting more than 40% of US children. Tobacco cessation quitlines are effective in helping smokers quit, but few smokers make use of their services. Electronic health record-based systems that automate referral of interested parents to quitlines through pediatric settings may increase the proportion of smokers who successfully enroll in treatment.
Primary Outcome
Proportion of parent smokers identified in clinic that enroll in quitline treatment compared across the intervention (electronic referral) and control (standard of practice) approaches. Primary analysis wibased on an intent to treat approach and includes all subjects randomized at their referral visit.
Conditions Studied
Interventions
- BEHAVIORAL Quitline Delivered Treatment
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 484 participants |
| Start Date | 2017-01-11 |
| Est. Completion | 2018-08 |
| Phase | NA |
What the finished NCT02997735 record still lists
NCT02997735 is an interventional study that assigns participants to a tested intervention. The registered 484 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Secondhand Smoke appearing as the primary indexed condition, and to 1 intervention - of which Quitline Delivered Treatment is the first listed.
NCT02997735 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02997735 about?
NCT02997735 is a clinical study titled "Parent eReferral to Tobacco Quitline". Secondhand smoke (SHS) exposure is a significant public health problem in that it both harms children and is widely prevalent, affecting more than 40% of US children. Tobacco cessation quitlines are effective in helping smokers quit, but few smokers make use of their services. Electronic health reco...
What is the current status of trial NCT02997735?
This trial is currently completed. It is a NA study. The enrollment target is 484 participants. The study started on 2017-01-11. Estimated completion is 2018-08.
What conditions does trial NCT02997735 study?
This clinical trial studies the following conditions: Secondhand Smoke.
What interventions are being tested in trial NCT02997735?
The interventions under investigation include: Quitline Delivered Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02997735?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02997735 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Secondhand Smoke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02997735's enrollment target sits among peer trials
484 216th of 2000 higher than 1,785 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI